Published in Mol Biochem Parasitol on September 01, 1997
Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun (2002) 1.45
Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect Immun (1998) 1.31
Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect Immun (2003) 1.15
Gene discovery through expressed sequence Tag sequencing in Trypanosoma cruzi. Infect Immun (1998) 1.06
Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J Clin Invest (1998) 1.01
Proteomic analysis of detergent-solubilized membrane proteins from insect-developmental forms of Trypanosoma cruzi. J Proteome Res (2009) 0.92
Silencing cytokeratin 18 gene inhibits intracellular replication of Trypanosoma cruzi in HeLa cells but not binding and invasion of trypanosomes. BMC Cell Biol (2008) 0.88
Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi. PLoS One (2013) 0.84
In silico, biologically-inspired modelling of genomic variation generation in surface proteins of Trypanosoma cruzi. Kinetoplastid Biol Dis (2007) 0.81
Genetic structure and expression of the surface glycoprotein GP82, the main adhesin of Trypanosoma cruzi metacyclic trypomastigotes. ScientificWorldJournal (2013) 0.76
A Brief View of the Surface Membrane Proteins from Trypanosoma cruzi. J Parasitol Res (2017) 0.76
Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease. Pathog Immun (2016) 0.75
The Trypanosoma cruzi proteome. Science (2005) 2.63
Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infect Dis (1999) 1.84
Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2. J Immunol (1984) 1.53
Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect Immun (1998) 1.31
The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol (1998) 1.31
Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. J Immunol (1997) 1.25
Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J Immunol (2001) 1.22
Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exp Parasitol (1996) 1.21
Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL. J Immunol (1998) 1.21
Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J Immunol (1997) 1.20
Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol (1996) 1.20
Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am J Trop Med Hyg (1993) 1.18
Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. J Immunol (1991) 1.12
Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp Parasitol (1991) 1.10
Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: correlations with parasite-specific antibody response. Cell Immunol (1983) 1.01
Measurement of parasite-specific immune responses in vitro: evidence for suppression of the antibody response to Trypanosoma cruzi. Eur J Immunol (1985) 0.99
Demonstration of IgG-Fc and C3 receptors on adult Schistosoma mansoni. J Immunol (1981) 0.95
The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family. Mol Biochem Parasitol (1997) 0.95
Proteins with glycosylphosphatidylinositol (GPI) signal sequences have divergent fates during a GPI deficiency. GPIs are essential for nuclear division in Trypanosoma cruzi. J Biol Chem (1997) 0.94
Trypanosoma cruzi: effect on B-cell-responsive and -responding clones. Exp Parasitol (1981) 0.94
Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. J Antimicrob Chemother (2012) 0.89
Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes. Infect Immun (1997) 0.87
Diagnosis of recent Toxoplasma gondii infection in cats by use of an enzyme-linked immunosorbent assay for immunoglobulin M. Am J Vet Res (1989) 0.87
Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin-2 enhancer. Eur J Immunol (1994) 0.86
Construction and use of a multi-competitor gene for quantitative RT-PCR using existing primer sets. J Immunol Methods (1995) 0.86
Analysis of the Trypanosoma cruzi cyclophilin gene family and identification of Cyclosporin A binding proteins. Parasitology (2006) 0.85
Endotoxin-induced tumor necrosis factor activity production by equine peritoneal macrophages. Circ Shock (1990) 0.84
Selective suppressive effects of Trypanosoma cruzi infection on IL-2, c-myc, and c-fos gene expression. J Immunol (1992) 0.84
Effects of extracts of Trypanosoma cruzi on immune responses: induction of a nonspecific suppressor factor. Infect Immun (1983) 0.83
Enzyme-linked immunosorbent assay for the detection of circulating antigens of Toxoplasma gondii in the serum of cats. Am J Vet Res (1989) 0.81
In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi. Int Arch Allergy Immunol (1994) 0.81
Measurement of parasite-specific antibody responses using a tritiated avidin-solid phase radioimmunoassay. J Immunol Methods (1983) 0.79
Loss of suppressor activity in the serum of mice infected with Trypanosoma cruzi. J Parasitol (1984) 0.78
Trypanosomes and microfilariae in feral owl and squirrel monkeys maintained in research colonies. Am J Trop Med Hyg (1993) 0.78
Diagnosis of Chagas' disease in humans using a biotin-3H-avidin radioimmunoassay. Am J Trop Med Hyg (1984) 0.78
A monoclonal antibody to alpha tubulin recognizes host cell and Trypanosoma cruzi tubulins. J Protozool (1988) 0.76
Mitomycin C-treated Trypanosoma cruzi in vaccination of mice: induction of immunosuppression but not protection. Infect Immun (1981) 0.75
A new liquid chromatography/tandem mass spectrometric approach for the identification of class I major histocompatibility complex associated peptides that eliminates the need for bioassays. Rapid Commun Mass Spectrom (1999) 0.75
Biology of tegument associated IgG-Fc and C3 receptors inSchistosoma mansoni. J Chem Ecol (1986) 0.75
Differentiation of trypanosomatid species by hybridization to selected rRNA probes. Mol Cell Probes (1993) 0.75